JAMIE RHOADS

Allopathic & Osteopathic Physicians|Dermatology MURRAY, UT NPI 1104093392

General Payments — all program years on this page

$73,895.72

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 78
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,139.84 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ARGENX US, INC. $1,500.001
Regeneron Pharmaceuticals, Inc. $1,415.699
Boehringer Ingelheim Pharmaceuticals, Inc. $1,112.201
Janssen Biotech, Inc. $94.991
ABBVIE INC. $16.961

By program year

Program yearAmountRecords
2020 $89.951
2021 $578.992
2022 $41,011.8739
2023 $28,075.0723
2024 $4,139.8413

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078788184 Janssen Biotech, Inc. $94.99 11/06/2024 Education Undisputed 01/23/2026 View at CMS
1105942298 ABBVIE INC. $16.96 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403983 Regeneron Pharmaceuticals, Inc. $35.25 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114403985 Regeneron Pharmaceuticals, Inc. $35.25 11/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114403987 Regeneron Pharmaceuticals, Inc. $731.42 11/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114403989 Regeneron Pharmaceuticals, Inc. $303.97 12/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114403991 Regeneron Pharmaceuticals, Inc. $125.71 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403993 Regeneron Pharmaceuticals, Inc. $47.71 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403995 Regeneron Pharmaceuticals, Inc. $67.77 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403997 Regeneron Pharmaceuticals, Inc. $35.62 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403999 Regeneron Pharmaceuticals, Inc. $32.99 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117872503 Boehringer Ingelheim Pharmaceuticals, Inc. $1,112.20 08/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1142113025 ARGENX US, INC. $1,500.00 06/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.